Paul Knight

Stock Analyst at KeyBanc

(3.35)

# 2,459

Out of 4,600 analysts

261

Total ratings

45.3%

Success rate

3.8%

Average return

Main Sectors:

Healthcare Industrials Technology

Top Industries:

Diagnostics & Research Medical Instruments & Supplies Medical Devices Biotechnology Drug Manufacturers - Specialty & Generic

Stocks Rated by Paul Knight

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	WST West Pharmaceutical Services	Maintained: Buy	$350 → $390	$348.76	+11.82%	16	Jul 2, 2026
	CSTL Castle Biosciences	Maintained: Buy	$50 → $35	$31.18	+12.25%	9	May 29, 2026
	RPID Rapid Micro Biosystems	Maintained: Buy	$8 → $5	$2.06	+142.72%	3	May 29, 2026
	CYRX Cryoport	Maintained: Buy	$15 → $17	$15.22	+11.70%	10	May 20, 2026
	TECH Bio-Techne	Maintained: Hold	n/a	$72.09	-	19	May 7, 2026
	XGN Exagen	Maintained: Buy	$15 → $10	$6.45	+55.04%	11	Mar 11, 2026
	STVN Stevanato Group	Rated: Buy	$37 → $32	$19.65	+62.85%	7	Mar 5, 2026
	TKNO Alpha Teknova	Maintained: Hold	n/a	$5.52	-	4	Feb 27, 2026
	LAB Standard BioTools	Maintained: Hold	n/a	$0.8205	-	9	Feb 25, 2026
	RGEN Repligen	Maintained: Buy	$220	$149.78	+46.88%	13	Feb 25, 2026
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Hold	n/a	$4.35	-	3	Dec 29, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Rated: Buy	$310	$194.78	+59.15%	9	Dec 18, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Upgraded: Buy	$750	$564.75	+32.80%	9	Dec 8, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Buy	€415.00 → €320.00	€227.60	+40.60%	2	Oct 7, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Buy	$33	$32.52	+1.48%	10	Oct 3, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Buy	$125	$111.39	+12.22%	12	Sep 16, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Buy	$220	$136.18	+61.55%	2	Sep 10, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Initiated Coverage: Buy	CHF 525.00	CHF 391.00	+34.27%	1	Sep 4, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Reiterated: Hold	n/a	$139.20	-	12	Aug 28, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Buy	$460	$396.08	+16.14%	9	Aug 18, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Reiterated: Buy	$40 → $30	$13.68	n/a	3	Jun 3, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Downgraded: Hold	$7 → $30	$6.31	n/a	9	Apr 9, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Downgraded: Hold	n/a	$27.32	n/a	2	Mar 31, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Reiterated: Hold	n/a	$101.18	n/a	3	Feb 5, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Buy	CHF 610.00 → CHF 635.00	CHF 556.40	n/a	6	Jan 30, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Rated: Hold	n/a	$6.43	n/a	9	May 9, 2024
	XXXX XXXXXXXXXXXXXXXX Upgrade	Rated: Hold	n/a	$30.13	n/a	9	Nov 14, 2023
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Buy	$300	$234.12	n/a	1	May 5, 2022
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Buy	$250	$228.20	n/a	1	Apr 28, 2022
	XXXX XXXXXXXXXXXXXXXX Upgrade	Downgraded: Hold	n/a	$5.12	n/a	6	Mar 14, 2022
	XXXX XXXXXXXXXXXXXXXX Upgrade	Initiated Coverage: Buy	n/a	$1.63	n/a	1	Apr 15, 2020
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Hold	$20 → $30	$16.29	n/a	3	Feb 27, 2020
	XXXX XXXXXXXXXXXXXXXX Upgrade	Downgraded: Hold	$6 → $2	$0.0005	n/a	8	Nov 26, 2019
	XXXX XXXXXXXXXXXXXXXX Upgrade	Downgraded: Hold	n/a	$5.45	n/a	2	Jul 24, 2019
	XXXX XXXXXXXXXXXXXXXX Upgrade	Downgraded: Hold	n/a	$46.41	n/a	7	Nov 29, 2018
	XXXX XXXXXXXXXXXXXXXX Upgrade	Upgraded: Hold	n/a	$203.01	n/a	6	Oct 23, 2017
	XXXX XXXXXXXXXXXXXXXX Upgrade	Downgraded: Hold	n/a	$50.30	n/a	4	Mar 27, 2017
	XXXX XXXXXXXXXXXXXXXX Upgrade	Downgraded: Hold	n/a	$0.9289	n/a	2	Mar 11, 2016
	XXXX XXXXXXXXXXXXXXXX Upgrade	Initiated Coverage: Buy	n/a	$47.09	n/a	1	Feb 10, 2016
	XXXX XXXXXXXXXXXXXXXX Upgrade	Downgraded: Hold	$75 → $85	$237.89	n/a	2	Jul 24, 2014
	XXXX XXXXXXXXXXXXXXXX Upgrade	Upgraded: Buy	n/a	$2.16	n/a	1	May 5, 2014
	XXXX XXXXXXXXXXXXXXXX Upgrade	Rated: Hold	$61 → $46	$11.81	n/a	2	Dec 19, 2013
	XXXX XXXXXXXXXXXXXXXX Upgrade	Initiated Coverage: Hold	$255	$1,437.00	n/a	1	Aug 15, 2013
	XXXX XXXXXXXXXXXXXXXX Upgrade	Initiated Coverage: Hold	$24	$42.33	n/a	1	Aug 15, 2013
	XXXX XXXXXXXXXXXXXXXX Upgrade	Initiated Coverage: Hold	$18	$0.3876	n/a	1	Aug 15, 2013

West Pharmaceutical Services

Jul 2, 2026

Maintained: Buy

Price Target: $350 → $390

Current: $348.76

Upside: +11.82%

Castle Biosciences

May 29, 2026

Maintained: Buy

Price Target: $50 → $35

Current: $31.18

Upside: +12.25%

Rapid Micro Biosystems

May 29, 2026

Maintained: Buy

Price Target: $8 → $5

Current: $2.06

Upside: +142.72%

Cryoport

May 20, 2026

Maintained: Buy

Price Target: $15 → $17

Current: $15.22

Upside: +11.70%

Bio-Techne

May 7, 2026

Maintained: Hold

Price Target: n/a

Current: $72.09

Upside: -

Exagen

Mar 11, 2026

Maintained: Buy

Price Target: $15 → $10

Current: $6.45

Upside: +55.04%

Stevanato Group

Mar 5, 2026

Rated: Buy

Price Target: $37 → $32

Current: $19.65

Upside: +62.85%

Alpha Teknova

Feb 27, 2026

Maintained: Hold

Price Target: n/a

Current: $5.52

Upside: -

Standard BioTools

Feb 25, 2026

Maintained: Hold

Price Target: n/a

Current: $0.8205

Upside: -

Repligen

Feb 25, 2026

Maintained: Buy

Price Target: $220

Current: $149.78

Upside: +46.88%

Dec 29, 2025

Maintained: Hold

Price Target: n/a

Current: $4.35

Upside: -

Dec 18, 2025

Rated: Buy

Price Target: $310

Current: $194.78

Upside: +59.15%

Dec 8, 2025

Upgraded: Buy

Price Target: $750

Current: $564.75

Upside: +32.80%

Oct 7, 2025

Maintained: Buy

Price Target: €415.00 → €320.00

Current: €227.60

Upside: +40.60%

Oct 3, 2025

Maintained: Buy

Price Target: $33

Current: $32.52

Upside: +1.48%

Sep 16, 2025

Maintained: Buy

Price Target: $125

Current: $111.39

Upside: +12.22%

Sep 10, 2025

Maintained: Buy

Price Target: $220

Current: $136.18

Upside: +61.55%

Sep 4, 2025

Initiated Coverage: Buy

Price Target: CHF 525.00

Current: CHF 391.00

Upside: +34.27%

Aug 28, 2025

Reiterated: Hold

Price Target: n/a

Current: $139.20

Upside: -

Aug 18, 2025

Maintained: Buy

Price Target: $460

Current: $396.08

Upside: +16.14%

Jun 3, 2025

Reiterated: Buy

Price Target: $40 → $30

Current: $13.68

Upside: n/a

Apr 9, 2025

Downgraded: Hold

Price Target: $7 → $30

Current: $6.31

Upside: n/a

Mar 31, 2025

Downgraded: Hold

Price Target: n/a

Current: $27.32

Upside: n/a

Feb 5, 2025

Reiterated: Hold

Price Target: n/a

Current: $101.18

Upside: n/a

Jan 30, 2025

Maintained: Buy

Price Target: CHF 610.00 → CHF 635.00

Current: CHF 556.40

Upside: n/a

May 9, 2024

Rated: Hold

Price Target: n/a

Current: $6.43

Upside: n/a

Nov 14, 2023

Rated: Hold

Price Target: n/a

Current: $30.13

Upside: n/a

May 5, 2022

Maintained: Buy

Price Target: $300

Current: $234.12

Upside: n/a

Apr 28, 2022

Maintained: Buy

Price Target: $250

Current: $228.20

Upside: n/a

Mar 14, 2022

Downgraded: Hold

Price Target: n/a

Current: $5.12

Upside: n/a

Apr 15, 2020

Initiated Coverage: Buy

Price Target: n/a

Current: $1.63

Upside: n/a

Feb 27, 2020

Maintained: Hold

Price Target: $20 → $30

Current: $16.29

Upside: n/a

Nov 26, 2019

Downgraded: Hold

Price Target: $6 → $2

Current: $0.0005

Upside: n/a

Jul 24, 2019

Downgraded: Hold

Price Target: n/a

Current: $5.45

Upside: n/a

Nov 29, 2018

Downgraded: Hold

Price Target: n/a

Current: $46.41

Upside: n/a

Oct 23, 2017

Upgraded: Hold

Price Target: n/a

Current: $203.01

Upside: n/a

Mar 27, 2017

Downgraded: Hold

Price Target: n/a

Current: $50.30

Upside: n/a

Mar 11, 2016

Downgraded: Hold

Price Target: n/a

Current: $0.9289

Upside: n/a

Feb 10, 2016

Initiated Coverage: Buy

Price Target: n/a

Current: $47.09

Upside: n/a

Jul 24, 2014

Downgraded: Hold

Price Target: $75 → $85

Current: $237.89

Upside: n/a

May 5, 2014

Upgraded: Buy

Price Target: n/a

Current: $2.16

Upside: n/a

Dec 19, 2013

Rated: Hold

Price Target: $61 → $46

Current: $11.81

Upside: n/a

Aug 15, 2013

Initiated Coverage: Hold

Price Target: $255

Current: $1,437.00

Upside: n/a

Aug 15, 2013

Initiated Coverage: Hold

Price Target: $24

Current: $42.33

Upside: n/a

Aug 15, 2013

Initiated Coverage: Hold

Price Target: $18

Current: $0.3876

Upside: n/a